97 related articles for article (PubMed ID: 18549145)
1. [The value of positron emission tomography in the diagnosis and treatment of oesophageal cancer].
Balink H; Gemmel FA; van Schelven WD
Ned Tijdschr Geneeskd; 2008 May; 152(20):1177-8; author reply 1178. PubMed ID: 18549145
[No Abstract] [Full Text] [Related]
2. [The value of positron emission tomography in the diagnosis and treatment of oesophageal cancer].
Omloo JM; Westerterp M; Sloof GW; Hoekstra OS; van Lanschot JJ
Ned Tijdschr Geneeskd; 2008 Feb; 152(7):365-70. PubMed ID: 18380382
[TBL] [Abstract][Full Text] [Related]
3. Reassessment of patients with esophageal cancer after neoadjuvant therapy.
Das A; Chak A
Endoscopy; 2006 Jun; 38 Suppl 1():S13-7. PubMed ID: 16802216
[No Abstract] [Full Text] [Related]
4. Positron emission tomography in the staging of esophageal cancer.
Leccisotti L
Rays; 2006; 31(1):9-12. PubMed ID: 16999368
[TBL] [Abstract][Full Text] [Related]
5. Is FDG-PET indicated for superficial esophageal cancer?
Little SG; Rice TW; Bybel B; Mason DP; Murthy SC; Falk GW; Rybicki LA; Blackstone EH
Eur J Cardiothorac Surg; 2007 May; 31(5):791-6. PubMed ID: 17337344
[TBL] [Abstract][Full Text] [Related]
6. F-18-fluorodeoxiglucose positron emission tomography for the evaluation of neoadjuvant therapy response in esophageal cancer.
Schmidt M; Bollschweiler E; Hölscher A
Ann Surg; 2010 Aug; 252(2):412-3; author reply 413. PubMed ID: 20647915
[No Abstract] [Full Text] [Related]
7. Staging stenotic oesophageal tumours: are CT and/or PET enough? Dilate or not?
Meenan J
Endoscopy; 2006 Jun; 38 Suppl 1():S8-12. PubMed ID: 16802215
[No Abstract] [Full Text] [Related]
8. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
Westerterp M; Van Westreenen HL; Sloof GW; Plukker JT; Van Lanschot JJ
Scand J Gastroenterol Suppl; 2006; (243):116-22. PubMed ID: 16782630
[TBL] [Abstract][Full Text] [Related]
9. Limited additional value of positron emission tomography in staging oesophageal cancer.
van Westreenen HL; Westerterp M; Sloof GW; Groen H; Bossuyt PM; Jager PL; Comans EF; van Dullemen HM; Fockens P; Stoker J; van der Jagt EJ; van Lanschot JJ; Plukker JT
Br J Surg; 2007 Dec; 94(12):1515-20. PubMed ID: 17902092
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography scanning in oesophageal cancer - stuck at the first hurdle?
Falk S
Clin Oncol (R Coll Radiol); 2012 Mar; 24(2):83-5. PubMed ID: 21865019
[No Abstract] [Full Text] [Related]
11. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
Salahudeen HM; Balan A; Naik K; Mirsadraee S; Scarsbrook AF
Clin Radiol; 2008 Jul; 63(7):765-73. PubMed ID: 18555034
[TBL] [Abstract][Full Text] [Related]
12. The diagnosis of esophageal cancer by 2-deoxy-2-F-18 fluoro-D-glucose positron emission tomography (F-18 FDG PET).
Alexander M; Brasić JR
Clin Nucl Med; 2006 Sep; 31(9):566-7. PubMed ID: 16921288
[No Abstract] [Full Text] [Related]
13. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
[TBL] [Abstract][Full Text] [Related]
14. Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.
Sloof GW
Best Pract Res Clin Gastroenterol; 2006; 20(5):941-57. PubMed ID: 16997171
[TBL] [Abstract][Full Text] [Related]
15. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
[TBL] [Abstract][Full Text] [Related]
16. Staging in oesophageal cancer.
Plukker JT; van Westreenen HL
Best Pract Res Clin Gastroenterol; 2006; 20(5):877-91. PubMed ID: 16997167
[TBL] [Abstract][Full Text] [Related]
17. Role of PET/PET CT in the staging and restaging of thoracic oesophageal cancer and gastro-oesophageal cancer: a literature review.
Wong WL; Chambers RJ
Abdom Imaging; 2008; 33(2):183-90. PubMed ID: 17619927
[TBL] [Abstract][Full Text] [Related]
18. Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer.
Yip C; Cook GJ; Landau DB; Davies A; Goh V
Dis Esophagus; 2016; 29(2):116-30. PubMed ID: 25604614
[No Abstract] [Full Text] [Related]
19. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
Katsoulis IE; Wong WL; Mattheou AK; Damani N; Chambers J; Livingstone JI
Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic radiology and nuclear medicine.
Castillo E; Lawler LP
J Surg Oncol; 2005 Dec; 92(3):191-202. PubMed ID: 16299788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
